| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 9.349 | 20.296 | 19.218 | 17.938 |
| Total Income - EUR | - | - | - | - | - | - | 9.349 | 20.310 | 19.237 | 18.111 |
| Total Expenses - EUR | - | - | - | - | - | - | 27.784 | 30.299 | 21.283 | 20.496 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -18.435 | -9.989 | -2.047 | -2.386 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -18.715 | -10.598 | -2.047 | -2.386 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oloproteic Diet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 10.023 | 7.947 | 5.822 | 3.700 |
| Current Assets | - | - | - | - | - | - | 16.011 | 8.360 | 8.966 | 13.160 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 283 | 6.235 | 5.121 |
| Cash | - | - | - | - | - | - | 16.011 | 8.077 | 2.731 | 8.040 |
| Shareholders Funds | - | - | - | - | - | - | -18.634 | -29.150 | -31.108 | -33.320 |
| Social Capital | - | - | - | - | - | - | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | - | - | 44.668 | 45.457 | 45.896 | 50.180 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Oloproteic Diet S.r.l.